338 related articles for article (PubMed ID: 20081837)
1. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
Lei X; Bai Z; Ye F; Xie J; Kim CG; Huang Y; Gao SJ
Nat Cell Biol; 2010 Feb; 12(2):193-9. PubMed ID: 20081837
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.
Yan Q; Ma X; Shen C; Cao X; Feng N; Qin D; Zeng Y; Zhu J; Gao SJ; Lu C
J Virol; 2014 May; 88(9):4987-5000. PubMed ID: 24554664
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma herpesvirus (KSHV) microRNA K12-1 functions as an oncogene by activating NF-κB/IL-6/STAT3 signaling.
Chen M; Sun F; Han L; Qu Z
Oncotarget; 2016 May; 7(22):33363-73. PubMed ID: 27166260
[TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus latent gene vFLIP inhibits viral lytic replication through NF-kappaB-mediated suppression of the AP-1 pathway: a novel mechanism of virus control of latency.
Ye FC; Zhou FC; Xie JP; Kang T; Greene W; Kuhne K; Lei XF; Li QH; Gao SJ
J Virol; 2008 May; 82(9):4235-49. PubMed ID: 18305042
[TBL] [Abstract][Full Text] [Related]
7. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway.
Li W; Jia X; Shen C; Zhang M; Xu J; Shang Y; Zhu K; Hu M; Yan Q; Qin D; Lee MS; Zhu J; Lu H; Krueger BJ; Renne R; Gao SJ; Lu C
Oncotarget; 2016 May; 7(22):32286-305. PubMed ID: 27058419
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
9. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
[TBL] [Abstract][Full Text] [Related]
10. Cellular microRNAs 498 and 320d regulate herpes simplex virus 1 induction of Kaposi's sarcoma-associated herpesvirus lytic replication by targeting RTA.
Yan Q; Li W; Tang Q; Yao S; Lv Z; Feng N; Ma X; Bai Z; Zeng Y; Qin D; Lu C
PLoS One; 2013; 8(2):e55832. PubMed ID: 23418466
[TBL] [Abstract][Full Text] [Related]
11. MiRNA-891a-5p mediates HIV-1 Tat and KSHV Orf-K1 synergistic induction of angiogenesis by activating NF-κB signaling.
Yao S; Hu M; Hao T; Li W; Xue X; Xue M; Zhu X; Zhou F; Qin D; Yan Q; Zhu J; Gao SJ; Lu C
Nucleic Acids Res; 2015 Oct; 43(19):9362-78. PubMed ID: 26446987
[TBL] [Abstract][Full Text] [Related]
12. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
13. Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use.
Beauclair G; Naimo E; Dubich T; Rückert J; Koch S; Dhingra A; Wirth D; Schulz TF
J Virol; 2020 Feb; 94(5):. PubMed ID: 31826996
[TBL] [Abstract][Full Text] [Related]
14. Human IFIT proteins inhibit lytic replication of KSHV: A new feed-forward loop in the innate immune system.
Li D; Swaminathan S
PLoS Pathog; 2019 Feb; 15(2):e1007609. PubMed ID: 30779786
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication.
Pantry SN; Medveczky PG
Semin Cancer Biol; 2009 Jun; 19(3):153-7. PubMed ID: 19429478
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
mBio; 2018 May; 9(3):. PubMed ID: 29739902
[TBL] [Abstract][Full Text] [Related]
17. miRNAs and their roles in KSHV pathogenesis.
Hussein HAM; Alfhili MA; Pakala P; Simon S; Hussain J; McCubrey JA; Akula SM
Virus Res; 2019 Jun; 266():15-24. PubMed ID: 30951791
[TBL] [Abstract][Full Text] [Related]
18. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency.
Mariggiò G; Koch S; Zhang G; Weidner-Glunde M; Rückert J; Kati S; Santag S; Schulz TF
PLoS Pathog; 2017 Apr; 13(4):e1006335. PubMed ID: 28430817
[TBL] [Abstract][Full Text] [Related]
19. A Kaposi's sarcoma-associated herpesvirus microRNA and its variants target the transforming growth factor β pathway to promote cell survival.
Lei X; Zhu Y; Jones T; Bai Z; Huang Y; Gao SJ
J Virol; 2012 Nov; 86(21):11698-711. PubMed ID: 22915806
[TBL] [Abstract][Full Text] [Related]
20. Ago HITS-CLIP expands understanding of Kaposi's sarcoma-associated herpesvirus miRNA function in primary effusion lymphomas.
Haecker I; Gay LA; Yang Y; Hu J; Morse AM; McIntyre LM; Renne R
PLoS Pathog; 2012; 8(8):e1002884. PubMed ID: 22927820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
